Health News Review
  • May 31 2012

    Medical research ethics whistleblower Nancy Olivieri honored again

    One of the saddest stories about drug company influence on clinical trials and on the integrity of research is the story of Dr. Nancy Olivieri. In 2009, the American Association for the Advancement of Science gave her its award for Scientific Freedom and Responsibility. AAAS wrote, at the time: In 1997, while conducting a clinical [...]

    No Comments 1 Star
  • May 14 2012

    Trying to keep up with health care ethics (mis)adventures

    Read Bill Heisel’s column, “Journalists Bag a Big One:  The American Pain Foundation.”  Excerpt: The American Pain Foundation – an industry funded promoter of painkillers masquerading as a patient advocacy organization – closed its doors last week after it became the target of a U.S. Senate panel inquiry. The action by the U.S. Senate Finance [...]

    No Comments 1 Star
  • Mar 21 2012

    “Too much ownership of data and secrecy involved”

    That’s what one author writes in a series of papers published in Circulation: Cardiovascular Quality and Outcomes this month addressing issues involving the integrity of research data. Yale’s Harlan Krumholz writes: “Patients facing a decision deserve information that is based on all of the evidence.”  Further excerpt: Every day, patients and their caregivers are faced [...]

    3 Comments 1 Star
  • Feb 22 2012

    Bioethics journal controversy reminds writers to be wary

    The following is a cross-post of a piece originally published on the Reporting on Health site by William Heisel, who is one of our story reviewers on HealthNewsReview.org. ———————————————————————————————————- Academic journals often have authoritative names: Cardiology, Neurology, Pediatrics. Not to be outdone by the bold founders of the origins-of-everything journal Cell, a group of academics [...]

    1 Comment 1 Star
  • Feb 9 2012

    Do patients always get all of the information they need from their physician?

    The following is a guest post by Harold DeMonaco, MS, a member of our editorial team, and Director of the Innovation Support Center at the Massachusetts General Hospital.  A graduate of the Massachusetts College of Pharmacy and Allied Health Sciences he holds a bachelors degree in pharmacy and a masters degree in therapeutics.  He has [...]

    No Comments 1 Star
  • Jan 12 2012

    Medical research misconduct a hot topic today

    The BMJ reports: “More than one in ten (13%) UK based scientists or doctors have witnessed colleagues intentionally altering or fabricating data during their research or for the purposes of publication, while 6% say they are aware of possible research misconduct at their institution that has not been properly investigated, reveals a BMJ survey published [...]

    No Comments 1 Star
  • Jan 6 2012

    Ten Commandments of “the new therapeutics”

    Sometimes I blog things that I see just to ensure that I have a place to keep them.  This is one of those times. Because this is a keeper. The Carlat Psychiatry Blog re-posted a list from BMJ blogger Richard Lehman – Ten Commandments for excellent clinical practice. The New Therapeutics: Ten Commandments Thou shalt treat [...]

    2 Comments 1 Star
  • Jan 6 2012

    Troubling TV news ethical issue – often on health news – now being reviewed by FCC

    “TV newscasts are increasingly seeded with corporate advertising masquerading as news — and the federal government wants to do something about it,” reports the Washington Post. It’s an issue that may have arisen more often with health news than with any other topic.  A quick (and probably incomplete) scan of this blog shows we’ve written [...]

    2 Comments 1 Star
  • May 25 2011

    Questions of bias in Medtronic-funded analysis of sterility in spine study

    John Fauber of the Milwaukee Journal Sentinel, in collaboration with MedPage Today, reports another in his series of reports on conflicts of interest in health care research. It begins: “Since 2002, the medical device company Medtronic and a group of doctors with financial ties to the company were aware that its new biological agent used [...]

    No Comments
  • Apr 26 2011

    Questions about academic freedom in continued scrutiny of Seroquel trial suicide

    Yesterday I saw journalists refer to the Wakefield autism/vaccine story as one that won’t go away. In the Twin Cities – but with a following far beyond this metropolitan area – the case of the suicide of a young man named Dan Markingson while in a trial of Seroquel at the University of Minnesota is [...]

    No Comments